Aclaris Therapeutics, Inc.

ACRS · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.6B · 73 employees
228
SEC Filings
$6.06
Close 2026-09-08
73
Employees

Business Summary

Aclaris Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel small and large molecule product candidates for immuno-inflammatory diseases. Its pipeline includes bosakitug (ATI-045), an anti-TSLP monoclonal antibody for atopic dermatitis; ATI-2138, an oral covalent ITK/JAK3 dual inhibitor; ATI-052, an anti-TSLP/anti-IL-4Ra bispecific antibody; and ATI-9494, a JAK-sparing ITK inhibitor. The company uses its proprietary KINect drug discovery platform and seeks third-party partnerships for further development and commercialization.

Latest Stock Quote

ACRS 2026-09-08 $6.06 O:$6.08 H:$6.145 L:$5.915 Vol:3.1M VWAP:$6.0491
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-14

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001104659-26-020540EDGAR88K words
2025-02-272024-12-310001558370-25-001819EDGAR92K words
2024-02-272023-12-310001558370-24-001753EDGAR76K words
2023-02-232022-12-310001558370-23-001829EDGAR74K words
2022-02-242021-12-310001558370-22-001838EDGAR—
2021-02-252020-12-310001558370-21-001717EDGAR—
2020-02-252019-12-310001558370-20-001325EDGAR—
2019-03-182018-12-310001558370-19-002211EDGAR—
2018-03-122017-12-310001558370-18-001866EDGAR—
2017-03-152016-12-310001558370-17-001802EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-062026-06-300001104659-26-092065EDGAR22K words
2025-11-062025-09-300001104659-25-107788EDGAR24K words
2025-08-072025-06-300001558370-25-010789EDGAR24K words
2025-05-082025-03-310001558370-25-006993EDGAR21K words
2024-11-062024-09-300001558370-24-014646EDGAR23K words
2024-08-072024-06-300001558370-24-011376EDGAR23K words
2024-05-072024-03-310001558370-24-007069EDGAR20K words
2023-11-062023-09-300001558370-23-017660EDGAR24K words
2023-08-072023-06-300001558370-23-013491EDGAR23K words
2023-05-082023-03-310001558370-23-008382EDGAR20K words
2022-11-082022-09-300001558370-22-016738EDGAR—
2022-08-032022-06-300001558370-22-011757EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-060001104659-26-091629EDGAR3K words
2026-08-060001104659-26-092128EDGAR22K words
2026-03-110001104659-26-026407EDGAR1K words
2026-03-100001104659-26-025420EDGAR1K words
2026-02-260001104659-26-020070EDGAR3K words
2026-01-120001104659-26-002694EDGAR7K words
2026-01-060001104659-26-001076EDGAR3K words
2025-11-060001104659-25-107353EDGAR3K words
2025-10-140001104659-25-098991EDGAR11K words
2025-08-070001558370-25-010640EDGAR3K words

228 total filings indexed. 196 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

immuno-inflammatory-diseases atopic-dermatitis asthma chronic-rhinosinusitis-with-nasal-polyps chronic-obstructive-pulmonary-disease autoimmune-diseases alopecia structure-based-drug-design-(sbdd) covalent-kinase-inhibition biparatopic-antibody-binding bispecific-antibody-engineering aqq-fc-mutation-for-effector-functionality-limitation fcrn-engineering-for-extended-half-life

Company Identity

CIK0001557746
TickerACRS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.aclaristx.com
Listed2015-10-07

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: eb0cf49f12203a2019c13716f55220c30958087bab1c97d456bfd5bec3f9ba95
parent: 04b7a99241851bbb641216463c22848520bcb41970e8eae1f8841a6308ed9f07
content hash: 50865448b828f334123b4f214c01124b271c70f4943f3105693de39a148a257c
signed: 2026-09-29T12:00:08.012Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ACRS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ACRS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ACRS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.